Uladzimir Antonenka

4 та иш

Bayer (Germany)

1. Population structure of drug-resistant Mycobacterium tuberculosis in Central Asia

   A. Engström, Uladzimir Antonenka, Abdylat Kadyrov +10

   МақолаTuberculosis Research and EpidemiologyBMC Infectious Diseases20191 иқтибос

   ABIABI:AkademIndex/openalex/2019.article.000129

2. Direct comparison of GeneXpert MTB/RIF (Cepheid) with probeTEC (Becton-Dickinson) and Taqman MTB (Roche) for detection of TB bacteria

   Harald Hoffmann, Sabine Hofmann-Thiel, Laziz Turaev +4

   МақолаPneumonia and Respiratory InfectionsPneumologie20120 иқтибос

   ABIABI:AkademIndex/openalex/2012.article.000304

3. Evaluation of the new, easy to perform, IS6110 based molecular assay Speed-oligo® Direct MTB (Vircell, Spain) for the detection of M. tuberculosis and direct comparison to probeTec (BD, USA)

   Uladzimir Antonenka, Sabine Hofmann-Thiel, A Esenalieva +4

   МақолаTuberculosis Research and EpidemiologyPneumologie20120 иқтибос

   ABIABI:AkademIndex/openalex/2012.article.000433

4. Comparison of Xpert MTB/RIF with ProbeTec ET DTB and COBAS TaqMan MTB for direct detection of M. tuberculosis complex in respiratory specimens

   Uladzimir Antonenka, Sabine Hofmann-Thiel, Laziz Turaev +5

   МақолаTuberculosis Research and EpidemiologyBMC Infectious Diseases20130 иқтибос

   ABIABI:AkademIndex/openalex/2013.article.000036